
CVD & Diabetes Prevention
Boston Heart Diagnostics
Sample type: Serum, Whole blood
Requires fasting: Yes
Phlebotomy is required for this test
Details
This panel screens for elevated lipids and inflammation and includes a full chemistry evaluation. It is often run when elevated blood sugars have been present in the past.
- Creatinine
- hsCRP
- Total Bilirubin
- Estimated Glomerular Filtration Rate
- Hemoglobin A1c
- Triglycerides
- Total Cholesterol
- Alkaline Phosphatase (ALP)
- Albumin
- Calcium
- Blood Urea Nitrogen
- Carbon Dioxide
- Chloride
- Potassium
- Sodium
- HDL Cholesterol
- Direct LDL
- Aspartate Aminotransferase (AST)
- Alanine Aminotransferase (ALT)
- Glucose, Fasting
- Protein, Total
- sdLDL
- Insulin, Fasting
- HOMA-IR
- HOMA-B
- HOMA-S
Estimated days for results: Results should arrive 14 business days after the lab receives samples.
This test is one of Boston Heart's 2 curated profiles for prevention of cardiovascular disease (CVD) and type-2 diabetes, or complication of these conditions. These profiles are excellent for monitoring patients with obesity, insulin resistance, metabolic syndrome, pre-diabetes, or diabetes. Such patients are at a 2 to 4 times higher risk for CVD than patients without these conditions.
Cardiovascular disease, type 2 diabetes, metabolic syndrome, and obesity are widespread and very common among patients. These lifestyle diseases are largely preventable, treatable, and reversible. The right combination of blood tests can unmask and monitor risk for serious health problems including premature death and dramatically reduced quality of life.
Advanced Lipid Testing
Routine lipid testing is insufficient to identify and monitor patients at risk adequately. Small Dense LDL-C, cholesterol production and absorption, and HDL metabolism are all important for uncovering and treating hidden risk.
Metabolics
Obesity, insulin resistance, metabolic syndrome, prediabetes, and type-2 diabetes are widespread epidemics. Cardiovascular disease is the leading cause of death in patients with these conditions. Monitoring glucose and HbA1c are crucially important for prevention, early identification, treatment, and reversal of type-2 diabetes and cardiovascular risk. These profiles go a step further by evaluating insulin levels, calculated insulin resistance & sensitivity, calculated beta cell activity, and the Boston Heart Beta Cell Function and Risk Index™. Together these tests can evaluate the potential role of specific therapies to address insulin resistance and/or beta cell dysfunction.
Inflammation
Atherosclerosis is an inflammatory disease which affects all patients with diabetes. After ruling out other causes of inflammation, C-reactive protein (CRP) is a strong independent predictor of CVD. Lowering CRP with statins in patients with normal LDL-C reduces CVD events.
Chemistries
Electrolytes, kidney function, liver function and other measures of normal metabolic activity are valuable tools for health assessment and patient management.
14 business days
Freeze the provided ice packs for 24 hours before your blood draw.
Fast for 8-12 hours before your blood draw. You may drink only water, black coffee, or tea without dairy or sugar.
Hydrate before your blood draw.
Minimum age:
5
State restrictions:
Patient can't order this test if they are located in Hawaii, Puerto Rico, New Jersey, New York, or Rhode Island




